XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Xtant Medical Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$0.29+0.00 (+1.50%)
Close on Oct 19, 2026
- Market cap
- $40.82M
- P/E (TTM)
- –
- Dividend yield
- –
Xtant Medical Holdings, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $115.20M | $115.77M | $91.30M | – | – | – | – | – | – | – | 86.0% | -0.5% |
| Orthobiologics [Member] | $72.89M | $66.42M | $58.61M | $47.14M | $42.26M | $39.31M | $46.66M | $48.98M | – | – | 54.4% | +9.7% |
| Spinal Implant [Member] | $42.31M | $49.35M | $32.70M | $10.83M | $12.89M | $13.88M | $17.87M | $22.83M | – | – | 31.6% | -14.3% |
| License Revenue [Member] | $18.72M | $1.50M | – | – | – | – | – | – | – | – | 14.0% | +1146.5% |
| License [Member] | $18.72M | $1.50M | – | – | – | – | – | – | – | – | 14.0% | +1146.5% |
| Bill and Hold Transactions [Member] | $400.00K | – | – | – | – | – | – | – | – | – | 0.3% | – |
| Independent Agents [Member] | – | – | – | – | – | – | – | $63.06M | – | – | – | – |
| Direct Sales [Member] | – | – | – | – | – | – | – | $8.75M | – | – | – | – |
| Other Revenue [Member] | – | – | – | $11.00K | $117.00K | $149.00K | $147.00K | $389.00K | – | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $122.45M | $105.52M | $85.86M | $57.16M | $54.57M | $52.15M | $62.38M | $68.88M | $79.74M | $85.62M | 91.4% | +16.0% |
| Non-US [Member] | $11.48M | $11.75M | – | – | – | – | – | – | – | – | 8.6% | -2.3% |
| Rest Of World [Member] | – | $11.75M | $5.44M | $807.00K | $693.00K | $1.19M | $2.31M | $3.32M | $2.87M | $4.38M | – | – |
From the segment and revenue-disaggregation notes of Xtant Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.